Global CRISPR-associated Nucleases Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global CRISPR-associated Nucleases Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
  • 1.2.2 Cas9
  • 1.2.3 Cas12
  • 1.2.4 Cas13
  • 1.2.5 Others
• 1.3 Market by Application
  • 1.3.1 Global CRISPR-associated Nucleases Market Share by Application: 2019 VS 2023 VS 2030
  • 1.3.2 Gene Editing Cell Line Construction
  • 1.3.3 Animal Models
  • 1.3.4 Bioagriculture
  • 1.3.5 Gene Therapy
  • 1.3.6 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global CRISPR-associated Nucleases Market Perspective (2019-2030)
• 2.2 Global CRISPR-associated Nucleases Growth Trends by Region
  • 2.2.1 Global CRISPR-associated Nucleases Market Size by Region: 2019 VS 2023 VS 2030
  • 2.2.2 CRISPR-associated Nucleases Historic Market Size by Region (2019-2024)
  • 2.2.3 CRISPR-associated Nucleases Forecasted Market Size by Region (2025-2030)
• 2.3 CRISPR-associated Nucleases Market Dynamics
  • 2.3.1 CRISPR-associated Nucleases Industry Trends
  • 2.3.2 CRISPR-associated Nucleases Market Drivers
  • 2.3.3 CRISPR-associated Nucleases Market Challenges
  • 2.3.4 CRISPR-associated Nucleases Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue CRISPR-associated Nucleases by Players
  • 3.1.1 Global CRISPR-associated Nucleases Revenue by Players (2019-2024)
  • 3.1.2 Global CRISPR-associated Nucleases Revenue Market Share by Players (2019-2024)
• 3.2 Global CRISPR-associated Nucleases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of CRISPR-associated Nucleases, Ranking by Revenue, 2022 VS 2023 VS 2024
• 3.4 Global CRISPR-associated Nucleases Market Concentration Ratio
  • 3.4.1 Global CRISPR-associated Nucleases Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by CRISPR-associated Nucleases Revenue in 2023
• 3.5 Global Key Players of CRISPR-associated Nucleases Head office and Area Served
• 3.6 Global Key Players of CRISPR-associated Nucleases, Product and Application
• 3.7 Global Key Players of CRISPR-associated Nucleases, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 CRISPR-associated Nucleases Breakdown Data by Type

• 4.1 Global CRISPR-associated Nucleases Historic Market Size by Type (2019-2024)
• 4.2 Global CRISPR-associated Nucleases Forecasted Market Size by Type (2025-2030)

5 CRISPR-associated Nucleases Breakdown Data by Application

• 5.1 Global CRISPR-associated Nucleases Historic Market Size by Application (2019-2024)
• 5.2 Global CRISPR-associated Nucleases Forecasted Market Size by Application (2025-2030)

6 North America

• 6.1 North America CRISPR-associated Nucleases Market Size (2019-2030)
• 6.2 North America CRISPR-associated Nucleases Market Size by Type
  • 6.2.1 North America CRISPR-associated Nucleases Market Size by Type (2019-2024)
  • 6.2.2 North America CRISPR-associated Nucleases Market Size by Type (2025-2030)
  • 6.2.3 North America CRISPR-associated Nucleases Market Share by Type (2019-2030)
• 6.3 North America CRISPR-associated Nucleases Market Size by Application
  • 6.3.1 North America CRISPR-associated Nucleases Market Size by Application (2019-2024)
  • 6.3.2 North America CRISPR-associated Nucleases Market Size by Application (2025-2030)
  • 6.3.3 North America CRISPR-associated Nucleases Market Share by Application (2019-2030)
• 6.4 North America CRISPR-associated Nucleases Market Size by Country
  • 6.4.1 North America CRISPR-associated Nucleases Market Size by Country: 2019 VS 2023 VS 2030
  • 6.4.2 North America CRISPR-associated Nucleases Market Size by Country (2019-2024)
  • 6.4.3 North America CRISPR-associated Nucleases Market Share by Country (2025-2030)
  • 6.4.4 United States
  • 6.4.5 Canada

7 Europe

• 7.1 Europe CRISPR-associated Nucleases Market Size (2019-2030)
• 7.2 Europe CRISPR-associated Nucleases Market Size by Type
  • 7.2.1 Europe CRISPR-associated Nucleases Market Size by Type (2019-2024)
  • 7.2.2 Europe CRISPR-associated Nucleases Market Size by Type (2025-2030)
  • 7.2.3 Europe CRISPR-associated Nucleases Market Share by Type (2019-2030)
• 7.3 Europe CRISPR-associated Nucleases Market Size by Application
  • 7.3.1 Europe CRISPR-associated Nucleases Market Size by Application (2019-2024)
  • 7.3.2 Europe CRISPR-associated Nucleases Market Size by Application (2025-2030)
  • 7.3.3 Europe CRISPR-associated Nucleases Market Share by Application (2019-2030)
• 7.4 Europe CRISPR-associated Nucleases Market Size by Country
  • 7.4.1 Europe CRISPR-associated Nucleases Market Size by Country: 2019 VS 2023 VS 2030
  • 7.4.2 Europe CRISPR-associated Nucleases Market Size by Country (2019-2024)
  • 7.4.3 Europe CRISPR-associated Nucleases Market Size by Country (2025-2030)
  • 7.4.4 Germany
  • 7.4.5 France
  • 7.4.6 U.K.
  • 7.4.7 Italy
  • 7.4.8 Russia
  • 7.4.9 Nordic Countries

8 China

• 8.1 China CRISPR-associated Nucleases Market Size (2019-2030)
• 8.2 China CRISPR-associated Nucleases Market Size by Type
  • 8.2.1 China CRISPR-associated Nucleases Market Size by Type (2019-2024)
  • 8.2.2 China CRISPR-associated Nucleases Market Size by Type (2025-2030)
  • 8.2.3 China CRISPR-associated Nucleases Market Share by Type (2019-2030)
• 8.3 China CRISPR-associated Nucleases Market Size by Application
  • 8.3.1 China CRISPR-associated Nucleases Market Size by Application (2019-2024)
  • 8.3.2 China CRISPR-associated Nucleases Market Size by Application (2025-2030)
  • 8.3.3 China CRISPR-associated Nucleases Market Share by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia CRISPR-associated Nucleases Market Size (2019-2030)
• 9.2 Asia CRISPR-associated Nucleases Market Size by Type
  • 9.2.1 Asia CRISPR-associated Nucleases Market Size by Type (2019-2024)
  • 9.2.2 Asia CRISPR-associated Nucleases Market Size by Type (2025-2030)
  • 9.2.3 Asia CRISPR-associated Nucleases Market Share by Type (2019-2030)
• 9.3 Asia CRISPR-associated Nucleases Market Size by Application
  • 9.3.1 Asia CRISPR-associated Nucleases Market Size by Application (2019-2024)
  • 9.3.2 Asia CRISPR-associated Nucleases Market Size by Application (2025-2030)
  • 9.3.3 Asia CRISPR-associated Nucleases Market Share by Application (2019-2030)
• 9.4 Asia CRISPR-associated Nucleases Market Size by Region
  • 9.4.1 Asia CRISPR-associated Nucleases Market Size by Region: 2019 VS 2023 VS 2030
  • 9.4.2 Asia CRISPR-associated Nucleases Market Size by Region (2019-2024)
  • 9.4.3 Asia CRISPR-associated Nucleases Market Size by Region (2025-2030)
  • 9.4.4 Japan
  • 9.4.5 South Korea
  • 9.4.6 China Taiwan
  • 9.4.7 Southeast Asia
  • 9.4.8 India
  • 9.4.9 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Size (2019-2030)
• 10.2 Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Size by Type (2019-2024)
  • 10.2.2 Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Size by Type (2025-2030)
  • 10.2.3 Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Share by Type (2019-2030)
• 10.3 Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Size by Application (2019-2024)
  • 10.3.2 Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Size by Application (2025-2030)
  • 10.3.3 Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Share by Application (2019-2030)
• 10.4 Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Size by Country: 2019 VS 2023 VS 2030
  • 10.4.2 Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Size by Country (2019-2024)
  • 10.4.3 Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Size by Country (2025-2030)
  • 10.4.4 Brazil
  • 10.4.5 Mexico
  • 10.4.6 Turkey
  • 10.4.7 Saudi Arabia
  • 10.4.8 Israel
  • 10.4.9 GCC Countries

11 Key Players Profiles

• 11.1 Thermo Fisher Scientific
  • 11.1.1 Thermo Fisher Scientific Company Details
  • 11.1.2 Thermo Fisher Scientific Business Overview
  • 11.1.3 Thermo Fisher Scientific CRISPR-associated Nucleases Introduction
  • 11.1.4 Thermo Fisher Scientific Revenue in CRISPR-associated Nucleases Business (2019-2024)
  • 11.1.5 Thermo Fisher Scientific Recent Development
• 11.2 GenScript
  • 11.2.1 GenScript Company Details
  • 11.2.2 GenScript Business Overview
  • 11.2.3 GenScript CRISPR-associated Nucleases Introduction
  • 11.2.4 GenScript Revenue in CRISPR-associated Nucleases Business (2019-2024)
  • 11.2.5 GenScript Recent Development
• 11.3 Integrated DNA Technologies, Inc.
  • 11.3.1 Integrated DNA Technologies, Inc. Company Details
  • 11.3.2 Integrated DNA Technologies, Inc. Business Overview
  • 11.3.3 Integrated DNA Technologies, Inc. CRISPR-associated Nucleases Introduction
  • 11.3.4 Integrated DNA Technologies, Inc. Revenue in CRISPR-associated Nucleases Business (2019-2024)
  • 11.3.5 Integrated DNA Technologies, Inc. Recent Development
• 11.4 Aldevron
  • 11.4.1 Aldevron Company Details
  • 11.4.2 Aldevron Business Overview
  • 11.4.3 Aldevron CRISPR-associated Nucleases Introduction
  • 11.4.4 Aldevron Revenue in CRISPR-associated Nucleases Business (2019-2024)
  • 11.4.5 Aldevron Recent Development
• 11.5 Merck
  • 11.5.1 Merck Company Details
  • 11.5.2 Merck Business Overview
  • 11.5.3 Merck CRISPR-associated Nucleases Introduction
  • 11.5.4 Merck Revenue in CRISPR-associated Nucleases Business (2019-2024)
  • 11.5.5 Merck Recent Development
• 11.6 Horizon Discovery
  • 11.6.1 Horizon Discovery Company Details
  • 11.6.2 Horizon Discovery Business Overview
  • 11.6.3 Horizon Discovery CRISPR-associated Nucleases Introduction
  • 11.6.4 Horizon Discovery Revenue in CRISPR-associated Nucleases Business (2019-2024)
  • 11.6.5 Horizon Discovery Recent Development
• 11.7 Agilent
  • 11.7.1 Agilent Company Details
  • 11.7.2 Agilent Business Overview
  • 11.7.3 Agilent CRISPR-associated Nucleases Introduction
  • 11.7.4 Agilent Revenue in CRISPR-associated Nucleases Business (2019-2024)
  • 11.7.5 Agilent Recent Development
• 11.8 OriGene Technologies, Inc
  • 11.8.1 OriGene Technologies, Inc Company Details
  • 11.8.2 OriGene Technologies, Inc Business Overview
  • 11.8.3 OriGene Technologies, Inc CRISPR-associated Nucleases Introduction
  • 11.8.4 OriGene Technologies, Inc Revenue in CRISPR-associated Nucleases Business (2019-2024)
  • 11.8.5 OriGene Technologies, Inc Recent Development
• 11.9 New England Biolabs
  • 11.9.1 New England Biolabs Company Details
  • 11.9.2 New England Biolabs Business Overview
  • 11.9.3 New England Biolabs CRISPR-associated Nucleases Introduction
  • 11.9.4 New England Biolabs Revenue in CRISPR-associated Nucleases Business (2019-2024)
  • 11.9.5 New England Biolabs Recent Development
• 11.10 NIPPON GENE CO., LTD.
  • 11.10.1 NIPPON GENE CO., LTD. Company Details
  • 11.10.2 NIPPON GENE CO., LTD. Business Overview
  • 11.10.3 NIPPON GENE CO., LTD. CRISPR-associated Nucleases Introduction
  • 11.10.4 NIPPON GENE CO., LTD. Revenue in CRISPR-associated Nucleases Business (2019-2024)
  • 11.10.5 NIPPON GENE CO., LTD. Recent Development
• 11.11 Novoprotein
  • 11.11.1 Novoprotein Company Details
  • 11.11.2 Novoprotein Business Overview
  • 11.11.3 Novoprotein CRISPR-associated Nucleases Introduction
  • 11.11.4 Novoprotein Revenue in CRISPR-associated Nucleases Business (2019-2024)
  • 11.11.5 Novoprotein Recent Development
• 11.12 Applied Biological Materials Inc. (abm)
  • 11.12.1 Applied Biological Materials Inc. (abm) Company Details
  • 11.12.2 Applied Biological Materials Inc. (abm) Business Overview
  • 11.12.3 Applied Biological Materials Inc. (abm) CRISPR-associated Nucleases Introduction
  • 11.12.4 Applied Biological Materials Inc. (abm) Revenue in CRISPR-associated Nucleases Business (2019-2024)
  • 11.12.5 Applied Biological Materials Inc. (abm) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details
• 13.3 Disclaimer

List of Tables

Table 1. Global CRISPR-associated Nucleases Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Cas9

Table 3. Key Players of Cas12

Table 4. Key Players of Cas13

Table 5. Key Players of Others

Table 6. Global CRISPR-associated Nucleases Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global CRISPR-associated Nucleases Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global CRISPR-associated Nucleases Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global CRISPR-associated Nucleases Market Share by Region (2019-2024)

Table 10. Global CRISPR-associated Nucleases Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global CRISPR-associated Nucleases Market Share by Region (2025-2030)

Table 12. CRISPR-associated Nucleases Market Trends

Table 13. CRISPR-associated Nucleases Market Drivers

Table 14. CRISPR-associated Nucleases Market Challenges

Table 15. CRISPR-associated Nucleases Market Restraints

Table 16. Global CRISPR-associated Nucleases Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global CRISPR-associated Nucleases Market Share by Players (2019-2024)

Table 18. Global Top CRISPR-associated Nucleases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR-associated Nucleases as of 2023)

Table 19. Global CRISPR-associated Nucleases Industry Ranking 2022 VS 2023

Table 20. Global 5 Largest Players Market Share by CRISPR-associated Nucleases Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of CRISPR-associated Nucleases, Headquarters and Area Served

Table 22. Global Key Players of CRISPR-associated Nucleases, Product and Application

Table 23. Global Key Players of CRISPR-associated Nucleases, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global CRISPR-associated Nucleases Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global CRISPR-associated Nucleases Revenue Market Share by Type (2019-2024)

Table 27. Global CRISPR-associated Nucleases Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global CRISPR-associated Nucleases Revenue Market Share by Type (2025-2030)

Table 29. Global CRISPR-associated Nucleases Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global CRISPR-associated Nucleases Revenue Market Share by Application (2019-2024)

Table 31. Global CRISPR-associated Nucleases Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global CRISPR-associated Nucleases Revenue Market Share by Application (2025-2030)

Table 33. North America CRISPR-associated Nucleases Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America CRISPR-associated Nucleases Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America CRISPR-associated Nucleases Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America CRISPR-associated Nucleases Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America CRISPR-associated Nucleases Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America CRISPR-associated Nucleases Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America CRISPR-associated Nucleases Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe CRISPR-associated Nucleases Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe CRISPR-associated Nucleases Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe CRISPR-associated Nucleases Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe CRISPR-associated Nucleases Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe CRISPR-associated Nucleases Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe CRISPR-associated Nucleases Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe CRISPR-associated Nucleases Market Size by Country (2025-2030) & (US$ Million)

Table 47. China CRISPR-associated Nucleases Market Size by Type (2019-2024) & (US$ Million)

Table 48. China CRISPR-associated Nucleases Market Size by Type (2025-2030) & (US$ Million)

Table 49. China CRISPR-associated Nucleases Market Size by Application (2019-2024) & (US$ Million)

Table 50. China CRISPR-associated Nucleases Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia CRISPR-associated Nucleases Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia CRISPR-associated Nucleases Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia CRISPR-associated Nucleases Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia CRISPR-associated Nucleases Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia CRISPR-associated Nucleases Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia CRISPR-associated Nucleases Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia CRISPR-associated Nucleases Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America CRISPR-associated Nucleases Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Size by Country (2025-2030) & (US$ Million)

Table 65. Thermo Fisher Scientific Company Details

Table 66. Thermo Fisher Scientific Business Overview

Table 67. Thermo Fisher Scientific CRISPR-associated Nucleases Product

Table 68. Thermo Fisher Scientific Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 69. Thermo Fisher Scientific Recent Development

Table 70. GenScript Company Details

Table 71. GenScript Business Overview

Table 72. GenScript CRISPR-associated Nucleases Product

Table 73. GenScript Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 74. GenScript Recent Development

Table 75. Integrated DNA Technologies, Inc. Company Details

Table 76. Integrated DNA Technologies, Inc. Business Overview

Table 77. Integrated DNA Technologies, Inc. CRISPR-associated Nucleases Product

Table 78. Integrated DNA Technologies, Inc. Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 79. Integrated DNA Technologies, Inc. Recent Development

Table 80. Aldevron Company Details

Table 81. Aldevron Business Overview

Table 82. Aldevron CRISPR-associated Nucleases Product

Table 83. Aldevron Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 84. Aldevron Recent Development

Table 85. Merck Company Details

Table 86. Merck Business Overview

Table 87. Merck CRISPR-associated Nucleases Product

Table 88. Merck Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 89. Merck Recent Development

Table 90. Horizon Discovery Company Details

Table 91. Horizon Discovery Business Overview

Table 92. Horizon Discovery CRISPR-associated Nucleases Product

Table 93. Horizon Discovery Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 94. Horizon Discovery Recent Development

Table 95. Agilent Company Details

Table 96. Agilent Business Overview

Table 97. Agilent CRISPR-associated Nucleases Product

Table 98. Agilent Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 99. Agilent Recent Development

Table 100. OriGene Technologies, Inc Company Details

Table 101. OriGene Technologies, Inc Business Overview

Table 102. OriGene Technologies, Inc CRISPR-associated Nucleases Product

Table 103. OriGene Technologies, Inc Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 104. OriGene Technologies, Inc Recent Development

Table 105. New England Biolabs Company Details

Table 106. New England Biolabs Business Overview

Table 107. New England Biolabs CRISPR-associated Nucleases Product

Table 108. New England Biolabs Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 109. New England Biolabs Recent Development

Table 110. NIPPON GENE CO., LTD. Company Details

Table 111. NIPPON GENE CO., LTD. Business Overview

Table 112. NIPPON GENE CO., LTD. CRISPR-associated Nucleases Product

Table 113. NIPPON GENE CO., LTD. Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 114. NIPPON GENE CO., LTD. Recent Development

Table 115. Novoprotein Company Details

Table 116. Novoprotein Business Overview

Table 117. Novoprotein CRISPR-associated Nucleases Product

Table 118. Novoprotein Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 119. Novoprotein Recent Development

Table 120. Applied Biological Materials Inc. (abm) Company Details

Table 121. Applied Biological Materials Inc. (abm) Business Overview

Table 122. Applied Biological Materials Inc. (abm) CRISPR-associated Nucleases Product

Table 123. Applied Biological Materials Inc. (abm) Revenue in CRISPR-associated Nucleases Business (2019-2024) & (US$ Million)

Table 124. Applied Biological Materials Inc. (abm) Recent Development

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

List of Figures

Figure 1. Global CRISPR-associated Nucleases Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global CRISPR-associated Nucleases Market Share by Type: 2023 VS 2030

Figure 3. Cas9 Features

Figure 4. Cas12 Features

Figure 5. Cas13 Features

Figure 6. Others Features

Figure 7. Global CRISPR-associated Nucleases Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global CRISPR-associated Nucleases Market Share by Application: 2023 VS 2030

Figure 9. Gene Editing Cell Line Construction Case Studies

Figure 10. Animal Models Case Studies

Figure 11. Bioagriculture Case Studies

Figure 12. Gene Therapy Case Studies

Figure 13. Other Case Studies

Figure 14. CRISPR-associated Nucleases Report Years Considered

Figure 15. Global CRISPR-associated Nucleases Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global CRISPR-associated Nucleases Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global CRISPR-associated Nucleases Market Share by Region: 2023 VS 2030

Figure 18. Global CRISPR-associated Nucleases Market Share by Players in 2023

Figure 19. Global Top CRISPR-associated Nucleases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR-associated Nucleases as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by CRISPR-associated Nucleases Revenue in 2023

Figure 21. North America CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America CRISPR-associated Nucleases Market Share by Type (2019-2030)

Figure 23. North America CRISPR-associated Nucleases Market Share by Application (2019-2030)

Figure 24. North America CRISPR-associated Nucleases Market Share by Country (2019-2030)

Figure 25. United States CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Canada CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe CRISPR-associated Nucleases Market Share by Type (2019-2030)

Figure 29. Europe CRISPR-associated Nucleases Market Share by Application (2019-2030)

Figure 30. Europe CRISPR-associated Nucleases Market Share by Country (2019-2030)

Figure 31. Germany CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. France CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. U.K. CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Italy CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Russia CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Nordic Countries CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. China CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. China CRISPR-associated Nucleases Market Share by Type (2019-2030)

Figure 39. China CRISPR-associated Nucleases Market Share by Application (2019-2030)

Figure 40. Asia CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Asia CRISPR-associated Nucleases Market Share by Type (2019-2030)

Figure 42. Asia CRISPR-associated Nucleases Market Share by Application (2019-2030)

Figure 43. Asia CRISPR-associated Nucleases Market Share by Region (2019-2030)

Figure 44. Japan CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. South Korea CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. China Taiwan CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Southeast Asia CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. India CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Australia CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Share by Type (2019-2030)

Figure 52. Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Share by Application (2019-2030)

Figure 53. Middle East, Africa, and Latin America CRISPR-associated Nucleases Market Share by Country (2019-2030)

Figure 54. Brazil CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Mexico CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Turkey CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Saudi Arabia CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Israel CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. GCC Countries CRISPR-associated Nucleases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. Thermo Fisher Scientific Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 61. GenScript Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 62. Integrated DNA Technologies, Inc. Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 63. Aldevron Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 64. Merck Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 65. Horizon Discovery Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 66. Agilent Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 67. OriGene Technologies, Inc Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 68. New England Biolabs Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 69. NIPPON GENE CO., LTD. Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 70. Novoprotein Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 71. Applied Biological Materials Inc. (abm) Revenue Growth Rate in CRISPR-associated Nucleases Business (2019-2024)

Figure 72. Bottom-up and Top-down Approaches for This Report

Figure 73. Data Triangulation

Figure 74. Key Executives Interviewed